Acetic Acid

Acetic Acid

SCHEMBL4357455

CC(=O)O.CC1(C)CCCCC1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.41
LCK P06239 1/20 0.41
FYN P06241 1/20 0.41
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
CYP2C19 P33261 2/20 0.37
APLNR P35414 1/20 0.36
TSHR P16473 2/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
BLM P54132 1/20 0.34
CACNA2D1 P54289 1/20 0.34
CYP3A4 P08684 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
NFKB1 P19838 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL6572045 0.91 FFAR3 (0.43) FFAR3ALDH1A1SMN1; SMN2CYP2C19APLNR
SCHEMBL28218916 0.86 FFAR3 (0.39) FFAR3ALDH1A1SMN1; SMN2CYP2C19APLNR
Methacrylic Acid SCHEMBL28231276 0.85 FFAR3 (0.35) FFAR3ALDH1A1SMN1; SMN2CYP2C19APLNR
Methacrylic Acid SCHEMBL4615017 0.85 FFAR3 (0.35) FFAR3ALDH1A1SMN1; SMN2CYP2C19APLNR
Methacrylic Acid SCHEMBL15388220 0.85 FFAR3 (0.35) FFAR3ALDH1A1SMN1; SMN2CYP2C19APLNR
Urea SCHEMBL1840880 0.82 ALDH1A1 (0.43) FFAR3ALDH1A1SMN1; SMN2CYP2C19TSHR
SCHEMBL14454696 0.81 FFAR3 (0.62) FFAR3ALDH1A1SMN1; SMN2CYP2C19APLNR
Acetic Acid Methyl Ester SCHEMBL17843668 0.81 ALDH1A1 (0.50) FFAR3ALDH1A1SMN1; SMN2TSHRCYP3A4
SCHEMBL13457323 0.81 FFAR3 (0.62) FFAR3ALDH1A1SMN1; SMN2CYP2C19APLNR
SCHEMBL18736277 0.81 FFAR3 (0.62) FFAR3ALDH1A1SMN1; SMN2CYP2C19APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4216713-B2 2009-01-28 JP claimed
EP-1404324-A4 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF XENOPORT INC (US) 2004-12-22 EP claimed
JP-2004536873-A 2004-12-09 JP claimed
EP-1404324-A2 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF Xenoport, Inc. (US) 2004-04-07 EP claimed
WO-2002100347-A2 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF XENOPORT, INC. (US) 2002-12-19 WO claimed
EP-1404324-A4 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF XENOPORT INC (US) 2004-12-22 EP disclosed
EP-1404324-A2 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF Xenoport, Inc. (US) 2004-04-07 EP disclosed
WO-2002100347-A2 PRODRUGS OF GABA ANALOGS, COMPOSITIONS AND USES THEREOF XENOPORT, INC. (US) 2002-12-19 WO disclosed